| scholarly article | Q13442814 |
| P50 | author | Atsushi Kato | Q42844846 |
| T Takahashi | Q84902164 | ||
| P2093 | author name string | Anju T Peters | |
| Whitney W Stevens | |||
| David B Conley | |||
| Robert C Kern | |||
| Kathleen E Harris | |||
| Leslie C Grammer | |||
| Robert P Schleimer | |||
| Bruce S Bochner | |||
| Bruce K Tan | |||
| Sergejs Berdnikovs | |||
| James E Norton | |||
| Lydia A Suh | |||
| Roderick G Carter | |||
| Kathryn E Hulse | |||
| Kevin C Welch | |||
| Stephanie Shintani-Smith | |||
| P2860 | cites work | Platelets amplify inflammation in arthritis via collagen-dependent microparticle production | Q24627618 |
| Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytes | Q24633568 | ||
| The basophil activation test by flow cytometry: recent developments in clinical studies, standardization and emerging perspectives | Q24815645 | ||
| Platelets in patients with aspirin-exacerbated respiratory disease | Q28080840 | ||
| EMR1, the human homolog of F4/80, is an eosinophil-specific receptor | Q28247107 | ||
| Flow cytometry for basophil activation markers: the measurement of CD203c up-regulation is as reliable as CD63 expression in the diagnosis of cat allergy | Q28286671 | ||
| The eosinophil surface receptor epidermal growth factor-like module containing mucin-like hormone receptor 1 (EMR1): a novel therapeutic target for eosinophilic disorders | Q28307714 | ||
| Membrane vesicles as conveyors of immune responses | Q29547765 | ||
| Evidence for distinct histologic profile of nasal polyps with and without eosinophilia | Q30424781 | ||
| Alterations in epithelial barrier function and host defense responses in chronic rhinosinusitis | Q33573943 | ||
| Natural history of aspirin-induced asthma. AIANE Investigators. European Network on Aspirin-Induced Asthma | Q33921113 | ||
| Clinical features and diagnosis of aspirin induced asthma | Q34036215 | ||
| Glandular mast cells with distinct phenotype are highly elevated in chronic rhinosinusitis with nasal polyps | Q34270916 | ||
| Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: A meta-analysis of the literature | Q34441715 | ||
| Association of circulating endothelial microparticles with cardiometabolic risk factors in the Framingham Heart Study | Q34469009 | ||
| Costimulation of mast cells by 4-1BB, a member of the tumor necrosis factor receptor superfamily, with the high-affinity IgE receptor. | Q34485933 | ||
| The development of nasal polyp disease involves early nasal mucosal inflammation and remodelling | Q35067772 | ||
| Corticosteroids, eosinophils and bronchial epithelial cells: new insights into the resolution of inflammation in asthma | Q35170065 | ||
| Oncostatin M promotes mucosal epithelial barrier dysfunction, and its expression is increased in patients with eosinophilic mucosal disease | Q36037454 | ||
| Aspirin-Exacerbated Respiratory Disease Involves a Cysteinyl Leukotriene-Driven IL-33-Mediated Mast Cell Activation Pathway | Q36119388 | ||
| Apoptosis and epithelial injury in the lungs | Q36284866 | ||
| Mast cells as effector cells: a co-stimulating question | Q36878227 | ||
| Clinical relevance of microparticles from platelets and megakaryocytes | Q37782534 | ||
| EpCAM: structure and function in health and disease | Q38101759 | ||
| Emerging role of extracellular vesicles in inflammatory diseases. | Q38188861 | ||
| The role of microparticles in chronic obstructive pulmonary disease | Q38202635 | ||
| Platelet microparticle: a sensitive physiological "fine tuning" balancing factor in health and disease | Q38323512 | ||
| Ectosomes and exosomes: shedding the confusion between extracellular vesicles | Q38356431 | ||
| Tips and tricks for flow cytometry-based analysis and counting of microparticles. | Q38646623 | ||
| Current and future treatment options for adult chronic rhinosinusitis: Focus on nasal polyposis | Q38665303 | ||
| Epithelial apoptosis is a prominent feature of the epithelial barrier disturbance in intestinal inflammation: effect of pro-inflammatory interleukin-13 on epithelial cell function. | Q39903368 | ||
| Significance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratification for cardiovascular events in patients at high risk for coronary heart disease | Q39957382 | ||
| Basophils are elevated in nasal polyps of patients with chronic rhinosinusitis without aspirin sensitivity | Q40126031 | ||
| The effects of glucocorticoids on human eosinophils | Q40554866 | ||
| Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis | Q40646486 | ||
| Immunologic stimulation of mast cells leads to the reversible exposure of phosphatidylserine in the absence of apoptosis | Q40838147 | ||
| CD44 and CD69 represent different types of cell-surface activation markers for human eosinophils | Q41031721 | ||
| Simplified protocol for flow cytometry analysis of fluorescently labeled exosomes and microvesicles using dedicated flow cytometer. | Q41126279 | ||
| Differences in the released endothelial microparticle subtypes between human pulmonary microvascular endothelial cells and aortic endothelial cells in vitro | Q42268357 | ||
| Features of mesenchymal transition in the airway epithelium from chronic rhinosinusitis | Q42463623 | ||
| CD203c expression on human basophils is associated with asthma exacerbation | Q43160533 | ||
| Increased CD62e(+) endothelial microparticle levels predict poor outcome in pulmonary hypertension patients | Q43739518 | ||
| Predicting outcomes of oral aspirin challenges in patients with asthma, nasal polyps, and chronic sinusitis | Q44432091 | ||
| Flow cytometric measurement of microparticles: pitfalls and protocol modifications | Q44802584 | ||
| A comparative study of myocardial injury during conventional and endovascular aortic aneurysm repair: measurement of cardiac troponin T and plasma cytokine release | Q46120004 | ||
| Increased circulating platelet microparticles as a potential biomarker in asthma. | Q46477681 | ||
| Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure | Q46726712 | ||
| Circulating endothelial microparticle levels predict hemodynamic severity of pulmonary hypertension | Q46836578 | ||
| Different types of T-effector cells orchestrate mucosal inflammation in chronic sinus disease | Q49156540 | ||
| Platelet activation markers overexpressed specifically in patients with aspirin-exacerbated respiratory disease | Q50439928 | ||
| Group 2 innate lymphoid cells (ILC2s) are increased in chronic rhinosinusitis with nasal polyps or eosinophilia. | Q51074774 | ||
| Aspirin-Exacerbated Respiratory Disease--New Prime Suspects. | Q51550145 | ||
| Defective epithelial barrier in chronic rhinosinusitis: the regulation of tight junctions by IFN-γ and IL-4. | Q52628047 | ||
| Mast cell and myeloid marker expression during early in vitro mast cell differentiation from human peripheral blood mononuclear cells. | Q52975007 | ||
| Exosome secretion by eosinophils: A possible role in asthma pathogenesis. | Q53636587 | ||
| IL-1β, IL-4 and IL-12 control the fate of group 2 innate lymphoid cells in human airway inflammation in the lungs. | Q53793238 | ||
| CD69 is expressed by human eosinophils activated in vivo in asthma and in vitro by cytokines | Q55094049 | ||
| Increased circulating endothelial microparticles in COPD patients: a potential biomarker for COPD exacerbation susceptibility | Q57705940 | ||
| Increased Ratio of CD31 + /CD42 − Microparticles to Endothelial Progenitors as a Novel Marker of Atherosclerosis in Hypercholesterolemia | Q58419259 | ||
| CD69 surface expression on human lung eosinophils after segmental allergen provocation. | Q64912718 | ||
| Quantitative, rather than qualitative, differences in CD69 upregulation in human blood eosinophils upon activation with selected stimuli | Q73569485 | ||
| Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation | Q73848313 | ||
| Increased CD69 expression on peripheral blood eosinophils after specific inhalation challenge | Q77999484 | ||
| Cellular Microparticles as a Marker for Cerebral Vasospasm in Spontaneous Subarachnoid Hemorrhage | Q84976859 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | aspirin | Q18216 |
| biomarker | Q864574 | ||
| rhinosinusitis | Q2148123 | ||
| chronic rhinosinusitis | Q55779961 | ||
| P304 | page(s) | 720-729 | |
| P577 | publication date | 2017-02-24 | |
| P1433 | published in | The Journal of Allergy and Clinical Immunology | Q7743550 |
| P1476 | title | Microparticles in nasal lavage fluids in chronic rhinosinusitis: Potential biomarkers for diagnosis of aspirin-exacerbated respiratory disease | |
| P478 | volume | 140 |
| Q89468973 | Current and Future Treatments of Rhinitis and Sinusitis |
| Q58796658 | Diagnostic value of platelet-derived microparticles in pulmonary thromboembolism: A population-based study |
| Q47566949 | Eosinophils and eosinophil-associated diseases: An update |
| Q99623687 | Increased airway T lymphocyte microparticles in chronic obstructive pulmonary disease induces airway epithelial injury |
| Q90342671 | Increased thrombin-activatable fibrinolysis inhibitor levels in patients with chronic rhinosinusitis with nasal polyps |
| Q89625756 | Inflammation, infection, and allergy of upper airways: new insights from national and real-world studies |
| Q57467935 | Pathophysiologic mechanisms of chronic rhinosinusitis and their roles in emerging disease endotypes |
| Q92622046 | Which Factors Associated With Activated Eosinophils Contribute to the Pathogenesis of Aspirin-Exacerbated Respiratory Disease? |
Search more.